Business Wire

NEDGROUP-INVESTMENTS

10.5.2023 09:50:27 CEST | Business Wire | Press release

Share
Nedgroup Investments expands boutique advantage range, onboards David Roberts and Alex Ralph to launch fixed income boutique

Nedgroup Investments, a global asset manager with over $20bn AUM, is launching an in-house multi-boutique platform which will feature a growing range of active investment strategies characterised by deep alignment of client and fund manager interests.

Tom Caddick, Managing Director of Nedgroup Investments (International) commented: “It's harder for boutiques to set up now because of the onerous regulatory requirements and the difficulty of raising sufficient capital. We want to facilitate start-up boutiques to better serve the needs of our clients and provide a wider range of investment opportunity. We can create a more diverse fund management sector for the benefit of the end investor. I’m thrilled to launch our innovative structure with two conviction managers I have known and respected for over 20 years.”

Fixed-income veterans David Roberts and Alex Ralph will run an active global bond fund as the first launch of these in-house managed strategies.

Roberts commented: “I have returned to active investing because market conditions are too compelling to ignore. I have always had conviction to invest when risk and reward are in the client’s favour. After a couple of years when return expectations were negative, we are back in an environment where fixed income is once again a diversifier, a very attractive alternative to equities. The old normal.”

Ralph adds: “Many have been waiting a decade for this type of entry point and the possibility of earning significant, long term positive returns without the need to venture into the dark, equity-like corners of the bond market.”

Addressing the attractions of the firm, Roberts commented: “Nedgroup Investment’s has a long-standing belief in the benefits to investors of boutique models and they share my client-centric approach. Those were the deciding factors for me. It is rare these days to find a business willing to innovate and support a boutique from inception.”

Apiramy Jeyarajah, who joined Nedgroup Investments as Chief Commercial Officer in April 2023, added: “Starting an investment boutique is increasingly difficult. We are excited to offer clients access to compelling teams, complementing the existing boutiques on our platform. Nurturing opportunities with experienced fund managers will help investors benefit from increased choice and a competitive edge.”

About Nedgroup Investments

Nedgroup Investments is a global asset manager with over $20 billion AUM with its international business led from London and global headquarters in Cape Town. Nedgroup Investments is known for its award winning ‘Best of Breed’ partnership model with leading boutique managers in London, Los Angeles, New York and Sydney, offering investors access to the world’s best managers and their funds.

The Nedgroup Investments Boutique Advantage Philosophy

Nedgroup Investments’ fundamental belief is that the best performing investment funds are run by managers that are autonomous, focused and have a concentrated alignment of interests with the unit-holders of their fund.

Fund Range

Nedgroup Investments has two fund ranges – Nedgroup Investments Funds Plc (launched in November 2008) and Nedgroup Investments Multifunds Plc (launched in August 2011).

About David Roberts

David Roberts is a fixed income investor with over 30 years’ experience. He is known for his skin in the game investment style and was previously head of fixed income at Liontrust until early 2022. Previously, he was a fund manager with Aegon Asset Management (formerly Kames Capital) where he was also co-head of fixed income and worked for 14 years. Prior to that, he held roles at Britannia Investment Managers and Lloyds Bank.

About Alex Ralph

Alex Ralph is a highly respected fixed-income fund manager with over two decades of experience in the industry. She is widely recognized for her strong track record of success and is considered one of the leading fixed-income investors of her generation. Alex was most recently a partner at Artemis Investment Management where she helped set up the bond desk launching the Strategic bond fund in 2005. In 2014, she was also appointed lead fund manager on the Artemis high income fund. The desk managed some £3 billion in credit by the end of her tenure at Artemis. Alex holds a BSc in Economics from London School of Economics and is a CFA Charter holder.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230509006145/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IQM Delivers Fourth Quantum Computer in Finland, Operational at Aalto University11.3.2026 11:32:00 CET | Press release

This is the fourth quantum computer deployed by IQM to customers in Finland to boost research and education in a growing ecosystem. The system named Aalto Q20 quantum computer is online at Aalto University and will enable students and scientists a unique first-hand access to a world-class quantum computer. The university will use the quantum computer to perform scientific experiments on advanced level and to support national and European quantum research activities. IQM Quantum Computers, the global leader in deployed on-premises, full-stack superconducting quantum computers, today announced the launch of Aalto Q20 quantum computer in Finland, reinforcing its commercial leadership in the quantum industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260311215316/en/ Ribbon cutting of the Aalto Q20 quantum computer delivered by IQM. The 20-qubit system, which is operational at Aalto University, is the fourth quantum compute

Chiesi and Bespak Partner to Advance Carbon Minimal Inhaler Production With UK Manufacturing Site11.3.2026 11:00:00 CET | Press release

Highlights Agreement builds on existing Chiesi-Bespak collaboration, reinforcing a trusted relationship as Chiesi works to evolve a portfolio of extrafine formulation Carbon Minimal Inhalers1, ensuring patients retain continuity of care while reducing carbon emissionsBespak’s leadership in low-GWP propellant inhaler manufacturing along with significant expansion at its Holmes Chapel site strengthens Chiesi’s global supply chain resiliencePartnership aligns with the science-based climate commitments of both companies Chiesi Group ("Chiesi"), the international research focused biopharmaceutical company and a certified B Corp, and Bespak, the specialist inhalation CDMO focused on pulmonary and nasal drug delivery, today announced an expansion of their long-standing partnership, increasing pressurized metered dose inhaler (pMDI) manufacturing capacity at Bespak’s Holmes Chapel site to support the next phase of Chiesi’s Carbon Minimal Inhaler (CMI) program. This press release features multi

NTT DATA Unveils NVIDIA-Powered Enterprise AI Factories to Support Secure AI Adoption and Help Clients Drive Measurable ROI11.3.2026 11:00:00 CET | Press release

NTT DATA drives success in healthcare, manufacturing and other sectors with NVIDIA-powered technologies NTT DATA AI solutions now integrate NVIDIA AI Enterprise software, including NVIDIA NeMo and NIM Microservices to create a full-stack, production-ready, GPU-accelerated agentic AI platform NTT DATA, a global leader in AI, digital business and technology services, announced an initiative to deliver NVIDIA-powered enterprise AI factories that drive innovation and operational excellence for organizations worldwide. NTT DATA’s new enterprise AI factories provide full-stack, domain-specific solutions that integrate data, infrastructure, workflows and governance to give organizations a repeatable and production-ready operating model for enterprise AI. NTT DATA enterprise AI factories, powered by NVIDIA, are adaptive, intelligent and automated ecosystems designed to help clients accelerate return on investment by scaling enterprise AI efficiently and managing the full AI lifecycle end to en

Haleon Strengthens Commitment to China as Consumers Focus on Better Everyday Health11.3.2026 10:00:00 CET | Press release

£65m investment in new oral health manufacturing plant in Shanghai to support growth in the world’s largest gum health market Haleon aiming to extend gum health brand parodontax to 30 Chinese cities by end of 2027 - including its fastest growing cities – reaching aspirational shoppers in-store and online Custom designed taste, foamier sensation and premium packaging to appeal to local consumers Haleon, a consumer company that is solely focused on better everyday health, is investing £65 million in a new state-of-the-art oral health manufacturing site in Shanghai. The facility will support the expansion of its oral care portfolio – which includes the global brands Sensodyne and parodontax – into China’s fast-growing tier 2 and tier 3 cities, where rising incomes, growing awareness of everyday health and a shift towards trusted, branded products are reshaping consumer behaviour. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202

Eurofins Biomnis Launches New Clinical LC‑MS/MS Method for the Detection of Cereulide Toxin in Stool Samples11.3.2026 09:00:00 CET | Press release

Eurofins Biomnis, a leading European provider of specialised clinical diagnostics services, and part of the global network of Eurofins laboratories, announces the successful development and validation of a new liquid chromatography tandem mass spectrometry (LC‑MS/MS) method for the detection and quantification of cereulide toxin in human stool samples. This innovation underlines Eurofins Biomnis’ diagnostic innovation, and its commitment to contributing its expertise to reducing diagnostic uncertainty with solutions that support clinicians and laboratories nationwide and internationally. Eurofins Biomnis has fully validated the method for human stool samples, taking into account matrix effects and meeting the requirements of ISO 15189 (with the exception of inter‑method comparison on pathological clinical samples). Cereulide, a toxin produced by specific strains of Bacillus cereus, has recently raised significant public attention following contamination events involving infant formula

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye